Naesens L - Search Results

1

Antiviral therapy for adenovirus infections.

Lenaerts L, Naesens L. Lenaerts L, et al. Among authors: naesens l. Antiviral Res. 2006 Sep;71(2-3):172-80. doi: 10.1016/j.antiviral.2006.04.007. Epub 2006 May 2. Antiviral Res. 2006. PMID: 16698093 Review.

2

Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.

Naesens L, Balzarini J, De Clercq E. Naesens L, et al. Antiviral Res. 1991 Jul;16(1):53-64. doi: 10.1016/0166-3542(91)90058-y. Antiviral Res. 1991. PMID: 1776876

3

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

Reymen D, Naesens L, Balzarini J, Holý A, Dvoráková H, De Clercq E. Reymen D, et al. Among authors: naesens l. Antiviral Res. 1995 Dec;28(4):343-57. doi: 10.1016/0166-3542(95)00058-5. Antiviral Res. 1995. PMID: 8669893

4

The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.

Naesens L, Balzarini J, De Clercq E. Naesens L, et al. Postepy Biochem. 1995;41(5 Suppl):347-51. Postepy Biochem. 1995. PMID: 8797236 Review. No abstract available.

5

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L. Snoeck R, et al. Among authors: naesens l. J Med Virol. 1998 Mar;54(3):219-25. doi: 10.1002/(sici)1096-9071(199803)54:3<219::aid-jmv13>3.0.co;2-c. J Med Virol. 1998. PMID: 9515772

6

Antitumor potential of acyclic nucleoside phosphonates.

De Clercq E, Andrei G, Balzarini J, Hatse S, Liekens S, Naesens L, Neyts J, Snoeck R. De Clercq E, et al. Among authors: naesens l. Nucleosides Nucleotides. 1999 Apr-May;18(4-5):759-71. doi: 10.1080/15257779908041563. Nucleosides Nucleotides. 1999. PMID: 10432678

7

Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.

Neyts J, Naesens L, Ying C, De Bolle L, De Clercq E. Neyts J, et al. Among authors: naesens l. Antiviral Res. 2001 Feb;49(2):115-20. doi: 10.1016/s0166-3542(00)00144-3. Antiviral Res. 2001. PMID: 11248363

8

Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.

De Clercq E, Andrei G, Snoeck R, De Bolle L, Naesens L, Degrève B, Balzarini J, Zhang Y, Schols D, Leyssen P, Ying C, Neyts J. De Clercq E, et al. Among authors: naesens l. Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):271-85. doi: 10.1081/NCN-100002298. Nucleosides Nucleotides Nucleic Acids. 2001. PMID: 11563039 Review.

9

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. De Clercq E, et al. Among authors: naesens l. Rev Med Virol. 2001 Nov-Dec;11(6):381-95. doi: 10.1002/rmv.336. Rev Med Virol. 2001. PMID: 11747000 Review.

10

Recent developments in herpesvirus therapy.

Naesens L, De Clercq E. Naesens L, et al. Herpes. 2001 Mar;8(1):12-6. Herpes. 2001. PMID: 11867011 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters